CRAIG ANTHONY L

CIK 00011869674 companiesNEW BRUNSWICK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001186967

Recent Transactions

50 trades

Exercise/Conversion
ARBINET Corp
Stock Option (right to buy)
2006-04-27$0.16/sh−184,861→ 10,000 total
Exercise/Conversion
ARBINET Corp
Common Stock
2006-04-27$0.16/sh+184,861→ 686,943 total
Exercise/Conversion
ARBINET Corp
Stock Option (right to buy)
2006-04-27$0.16/sh−184,861→ 10,000 total
Exercise/Conversion
ARBINET Corp
Common Stock
2006-04-27$0.16/sh+184,861→ 686,943 total
Sale
ARBINET Corp
Common Stock
2004-12-21$16.27/sh−25,000→ 412,812 total
Sale
ARBINET Corp
Common Stock
2004-12-21$16.27/sh−25,000→ 412,812 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.83/sh+400→ 400 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.87/sh+8,000→ 11,300 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.83/sh+400→ 400 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.86/sh+200→ 11,500 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.85/sh+2,900→ 3,300 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.88/sh+3,500→ 15,000 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.86/sh+200→ 11,500 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.85/sh+2,900→ 3,300 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.87/sh+8,000→ 11,300 total
Purchase
SAFEGUARD SCIENTIFICS INC$SFES
Common Stock
2004-08-09$1.88/sh+3,500→ 15,000 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−591,775→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+1,934,217→ 1,934,217 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−10,235→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+33,454→ 33,454 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+33,454→ 33,454 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−591,775→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−591,775→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+33,454→ 33,454 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+1,934,217→ 1,934,217 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−56,674→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−10,235→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−10,235→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+33,454→ 33,454 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−56,674→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−591,775→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+1,934,217→ 1,934,217 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+1,934,217→ 1,934,217 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+33,454→ 33,454 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−10,235→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−591,775→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+33,454→ 33,454 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−591,775→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+1,934,217→ 1,934,217 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+33,454→ 33,454 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series B Preferred Stock
2004-04-28−3,276,660→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock
2004-04-28+1,934,217→ 1,934,217 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−591,775→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Series C Preferred Stock
2004-04-28−10,235→ 0 total

Companies

Recent Filings

Address

C/O ARBINET-THEXCHANGE, INC. 120 ALBANY STREET, TOWER II, SUITE 450

NEW BRUNSWICK, NJ, 08901

View on SEC.gov